OBJECTIVES: Adapt a measure of frailty for use in a cohort study of European men and explore relationships with age, health related quality of life and falls. DESIGN: Longitudinal cohort study. SETTING: 8 European centers. PARTICIPANTS: 3047 men aged 40-79 participating in the European Male Ageing Study (EMAS). MEASUREMENTS: Frailty was assessed using an adaptation of the Cardiovascular Health Study criteria. Health related quality of life was evaluated using the Rand Short Form-36 (SF-36) questionnaire which comprises both mental and physical component scores. Self reported falls in the preceding 12 months were recorded at 2-year follow-up. RESULTS: 78 men (2.6%) were classified as frail (≥3 criteria) and 821 (26.9%) as prefrail (1-2 criteria). The prevalence of frailty increased from 0.1% in men aged 40-49 up to 6.8% in men aged 70-79. Compared to robust men, both prefrail and frail men had lower health related quality of life. Frailty was more strongly associated with the physical than mental subscales of the SF-36. Frailty was associated with higher risk of falls OR (95% CI) 2.92 (1.52, 5.59). CONCLUSIONS: Frailty, assessed by the EMAS criteria, increased in prevalence with age and was related to poorer health related quality of life and higher risk of falls in middle-aged and older European men. These criteria may help to identify a vulnerable subset of older men.
OBJECTIVES: Adapt a measure of frailty for use in a cohort study of European men and explore relationships with age, health related quality of life and falls. DESIGN: Longitudinal cohort study. SETTING: 8 European centers. PARTICIPANTS: 3047 men aged 40-79 participating in the European Male Ageing Study (EMAS). MEASUREMENTS: Frailty was assessed using an adaptation of the Cardiovascular Health Study criteria. Health related quality of life was evaluated using the Rand Short Form-36 (SF-36) questionnaire which comprises both mental and physical component scores. Self reported falls in the preceding 12 months were recorded at 2-year follow-up. RESULTS: 78 men (2.6%) were classified as frail (≥3 criteria) and 821 (26.9%) as prefrail (1-2 criteria). The prevalence of frailty increased from 0.1% in men aged 40-49 up to 6.8% in men aged 70-79. Compared to robust men, both prefrail and frail men had lower health related quality of life. Frailty was more strongly associated with the physical than mental subscales of the SF-36. Frailty was associated with higher risk of falls OR (95% CI) 2.92 (1.52, 5.59). CONCLUSIONS: Frailty, assessed by the EMAS criteria, increased in prevalence with age and was related to poorer health related quality of life and higher risk of falls in middle-aged and older European men. These criteria may help to identify a vulnerable subset of older men.
Authors: M Ritt; C Schwarz; V Kronawitter; A Delinic; L C Bollheimer; K G Gassmann; C C Sieber Journal: J Nutr Health Aging Date: 2015-12 Impact factor: 4.075
Authors: Thang S Han; Elon Correa; Michael E J Lean; David M Lee; Terrence W O'Neill; György Bartfai; Gianni Forti; Aleksander Giwercman; Krzysztof Kula; Neil Pendleton; Margus Punab; Martin K Rutter; Dirk Vanderschueren; Ilpo T Huhtaniemi; Frederick C W Wu; Felipe F Casanueva Journal: Endocrine Date: 2016-10-13 Impact factor: 3.633
Authors: Michael J Cook; Alexander Oldroyd; Stephen R Pye; Kate A Ward; Evelien Gielen; Rathi Ravindrarajah; Judith E Adams; David M Lee; Gyorgy Bartfai; Steven Boonen; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Michael E Lean; Neil Pendleton; Margus Punab; Dirk Vanderschueren; Frederick C Wu; Terence W O'Neill Journal: Age Ageing Date: 2017-07-01 Impact factor: 10.668
Authors: Agnieszka Swiecicka; Robert J A H Eendebak; Mark Lunt; Terence W O'Neill; György Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Jolanta Slowikowska-Hilczer; Michael E J Lean; Neil Pendleton; Margus Punab; Dirk Vanderschueren; Ilpo T Huhtaniemi; Frederick C W Wu; Martin K Rutter Journal: J Clin Endocrinol Metab Date: 2018-02-01 Impact factor: 5.958
Authors: Agnieszka Swiecicka; Mark Lunt; Tomás Ahern; Terence W O'Neill; György Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Michael E J Lean; Neil Pendleton; Margus Punab; Jolanta Slowikowska-Hilczer; Dirk Vanderschueren; Ilpo T Huhtaniemi; Frederick C W Wu; Martin K Rutter Journal: J Clin Endocrinol Metab Date: 2017-08-01 Impact factor: 5.958